FilingReader Intelligence

Wantai Bio opens account, signs funds supervision agreement

March 17, 2025 at 07:02 AM UTCBy FilingReader AI

Beijing Wantai Biological Pharmacy Enterprise (SSE: 603392) announced the opening of a dedicated settlement account for financial management related to its non-public offering, which raised approximately RMB 3.46 billion after expenses. The offering, approved in 2022, involved the issuance of 25,862,705 new shares at RMB 135.33 per share.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →